BioAnalytix Information
Contact top employees from
BioAnalytix
Summary
BioAnalytix is a private company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Health Care Technology areas. The position of the President & CEO is occupied by Kirtland Poss. Its headquarters is located at Boston, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of BioAnalytix varies between 5.0M and 25M. Total funding of the company - $4.6M. To connect with BioAnalytix employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
Advanced Analytics, Biologic Therapeutics, Mass Spec, Drug Development, Biopharma
SIC Code
8090
DMA Code
Greater Boston
Founded
2012
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Contact BioAnalytix
Organization Website
Contact Email
contact@protagenproteinservices.com
Phone Number
617-373-2051
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2012 | - | 100-200 | - | $- | |
| - | - | 10-50 | - | $- |
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at BioAnalytix shows a diverse range of experience levels:
7% for 1–2 years29% for 3–4 years21% for 5–7 years21% for 8–10 years21% have over 11 years of service at BioAnalytixEx-employees positions
In Company
In New Company
Contact top employees from
BioAnalytix
Xiaomei He
Principal Scientist
John Ziolkowski
CFO
Company Employee
Chief Executive Officer
Similar Companies
FAQ
BioAnalytix operates in the Biotechnology industries. More details can be found on the official website: bioanalytixinc.com.
The headquarters of BioAnalytix are located in Cambridge, United States.
The current CEO of BioAnalytix is Kirtland Poss
You can contact BioAnalytix by phone at 617-373-2051.
BioAnalytix currently employs 10-50 people.
BioAnalytix's revenue is approximately 11.9M.
Well-known competitors of BioAnalytix include ImprimisRx® - A Harrow Company and Sienna Biopharmaceuticals.
